Assembly Biosciences Inc. (ASMB)
NASDAQ · Healthcare
Assembly Biosciences Inc. Shareholder Equity 2016–2025
Assembly Biosciences Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Assembly Biosciences Inc. shareholder equity as of December 31, 2025: 206.8M, a 519.78% increase year-over-year.
- Assembly Biosciences Inc. shareholder equity for 2025 were 206.8M, a 519.78% increase from 2024.
- Assembly Biosciences Inc. shareholder equity for 2024 were 33.4M, a 18.83% decrease from 2023.
- Assembly Biosciences Inc. shareholder equity for 2023 were 41.1M, a 50.28% decrease from 2022.
- Assembly Biosciences Inc. shareholder equity for 2022 were 82.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Assembly Biosciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $207 |
| 2024 | $33 |
| 2023 | $41 |
| 2022 | $83 |
| 2021 | $169 |
| 2020 | $241 |
| 2019 | $273 |
| 2018 | $211 |
| 2017 | $113 |
| 2016 | $80 |
Assembly Biosciences Inc. Shareholder Equity — FAQ
Assembly Biosciences Inc. (ASMB) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ASMB's shareholder equity history?
The chart and table above show Assembly Biosciences Inc.'s shareholder equity by year and by quarter, including the growth rate.